Similar articles for PMID: 11322350

Year	Number of Results
1975	1
1976	1
1978	2
1979	1
1980	1
1981	1
1984	1
1986	1
1987	2
1988	2
1990	3
1991	2
1992	1
1993	2
1994	2
1995	3
1996	2
1997	8
1998	8
1999	17
2000	17
2001	28
2002	34
2003	26
2004	26
2005	27
2006	20
2007	10
2008	21
2009	17
2010	12
2011	6
2012	18
2013	9
2014	13
2015	10
2016	10
2017	13
2018	15
2019	15
2020	10
2021	3
2022	2
2023	5
2024	0

1

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.

Appell RA, Sand P, Dmochowski R, Anderson R, Zinner N, Lama D, Roach M, Miklos J, Saltzstein D, Boone T, Staskin DR, Albrecht D; Overactive Bladder: Judging Effective Control and Treatment Study Group. Appell RA, et al. Mayo Clin Proc. 2001 Apr;76(4):358-63. Mayo Clin Proc. 2001. PMID: 11322350 Clinical Trial.

2

Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.

Diokno AC, Appell RA, Sand PK, Dmochowski RR, Gburek BM, Klimberg IW, Kell SH; OPERA Study Group. Diokno AC, et al. Mayo Clin Proc. 2003 Jun;78(6):687-95. doi: 10.4065/78.6.687. Mayo Clin Proc. 2003. PMID: 12934777 Clinical Trial.

3

A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women.

Sand PK, Miklos J, Ritter H, Appell R. Sand PK, et al. Int Urogynecol J Pelvic Floor Dysfunct. 2004 Jul-Aug;15(4):243-8. doi: 10.1007/s00192-004-1161-9. Int Urogynecol J Pelvic Floor Dysfunct. 2004. PMID: 15517668 Clinical Trial.

4

Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial.

Homma Y, Paick JS, Lee JG, Kawabe K; Japanese and Korean Tolterodine Study Group. Homma Y, et al. BJU Int. 2003 Nov;92(7):741-7. doi: 10.1046/j.1464-410x.2003.04468.x. BJU Int. 2003. PMID: 14616458 Clinical Trial.

5

Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.

Armstrong RB, Dmochowski RR, Sand PK, Macdiarmid S. Armstrong RB, et al. Int Urol Nephrol. 2007;39(4):1069-77. doi: 10.1007/s11255-006-9157-7. Epub 2007 Mar 2. Int Urol Nephrol. 2007. PMID: 17333521 Clinical Trial.

6

Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder.

Anderson RU, MacDiarmid S, Kell S, Barada JH, Serels S, Goldberg RP. Anderson RU, et al. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Sep;17(5):502-11. doi: 10.1007/s00192-005-0057-7. Epub 2006 May 3. Int Urogynecol J Pelvic Floor Dysfunct. 2006. PMID: 16724169 Clinical Trial.

7

Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.

Khullar V, Hill S, Laval KU, Schiøtz HA, Jonas U, Versi E. Khullar V, et al. Urology. 2004 Aug;64(2):269-74; discussion 274-5. doi: 10.1016/j.urology.2004.02.029. Urology. 2004. PMID: 15302476 Clinical Trial.

8

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder.

Abrams P, Freeman R, Anderström C, Mattiasson A. Abrams P, et al. Br J Urol. 1998 Jun;81(6):801-10. doi: 10.1046/j.1464-410x.1998.00717.x. Br J Urol. 1998. PMID: 9666761 Clinical Trial.

9

Which anticholinergic drug for overactive bladder symptoms in adults.

Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJ. Madhuvrata P, et al. Cochrane Database Syst Rev. 2012 Jan 18;1:CD005429. doi: 10.1002/14651858.CD005429.pub2. Cochrane Database Syst Rev. 2012. PMID: 22258963 Review.

10

Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

Van Kerrebroeck P, Kreder K, Jonas U, Zinner N, Wein A; Tolterodine Study Group. Van Kerrebroeck P, et al. Urology. 2001 Mar;57(3):414-21. doi: 10.1016/s0090-4295(00)01113-4. Urology. 2001. PMID: 11248608 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

395 results

Results by year